Neith Corporation (6236.TWO)
TWD 29.65
(0.0%)
TWD 29.65
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 66.87 Million TWD | 57.62% |
| 2022 | 42.42 Million TWD | 79.0% |
| 2021 | 23.7 Million TWD | -19.75% |
| 2020 | 29.53 Million TWD | -25.54% |
| 2019 | 39.66 Million TWD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 17.57 Million TWD | -4.92% |
| 2024 Q2 | 20.64 Million TWD | 17.45% |
| 2023 FY | 66.87 Million TWD | 57.62% |
| 2023 Q4 | 18.48 Million TWD | 16.39% |
| 2023 Q3 | 15.88 Million TWD | -10.76% |
| 2023 Q2 | 17.79 Million TWD | 20.95% |
| 2023 Q1 | 14.71 Million TWD | 18.22% |
| 2022 Q4 | 12.44 Million TWD | 0.0% |
| 2022 FY | 42.42 Million TWD | 79.0% |
| 2021 FY | 23.7 Million TWD | -19.75% |
| 2020 FY | 29.53 Million TWD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -20226.14% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 127.67 Million TWD | 47.62% |
| Level Biotechnology Inc. | 151.99 Million TWD | 56.003% |
| Sagittarius Life Science Corp | 135.85 Million TWD | 50.775% |
| NeoCore Technology Co., Ltd. | 75.85 Million TWD | 11.846% |
| TaiMed Biologics Inc. | 225.23 Million TWD | 70.309% |
| GlycoNex Incorporation | 995 Thousand TWD | -6620.905% |
| VBI | 32.55 Million TWD | -105.415% |
| GeneReach Biotechnology Corp. | 256.86 Million TWD | 73.966% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 194.18 Million TWD | 65.562% |
| SynCore Biotechnology Co.,Ltd | 46.02 Million TWD | -45.303% |
| Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | 44.231% |
| Visgeneer Inc. | 67.48 Million TWD | 0.902% |
| Mycenax Biotech Inc. | -375.19 Million TWD | 117.824% |
| Sunmax Biotechnology Co., Ltd. | 510.09 Million TWD | 86.89% |
| G&E Herbal Biotechnology Co., Ltd. | 63.9 Million TWD | -4.648% |
| Medigen Vaccine Biologics Corporation | 1.44 Billion TWD | 95.369% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 29.35 Million TWD | -127.831% |
| Enimmune corporation | 220.1 Million TWD | 69.617% |
| TaiRx, Inc. | 217.13 Million TWD | 69.202% |
| CHO Pharma, Inc. | 268.99 Million TWD | 75.14% |
| EirGenix Inc. | 236.74 Million TWD | 71.753% |
| BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | 35.915% |
| Sunny Pharmtech Inc. | 357.62 Million TWD | 81.301% |
| Lin BioScience, Inc. | 1.09 Billion TWD | 93.903% |
| BioGend Therapeutics Co., Ltd. | 266.15 Million TWD | 74.875% |
| Feng Chi Biotech Corp. | 49.47 Million TWD | -35.176% |
| Bio Preventive Medicine Corp. | 1.08 Million TWD | -6074.792% |
| Lukas Biomedical Inc. | 177.45 Million TWD | 62.314% |
| RBC Bioscience Corporation | 58.35 Million TWD | -14.595% |
| BiOptic Inc. | 108.69 Million TWD | 38.475% |
| BRIM Biotechnology, Inc. | 90 Thousand TWD | -74203.333% |
| Shine-On BioMedical Co.,Ltd. | 69.35 Million TWD | 3.572% |
| Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | -2457.285% |
| Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 89.615% |
| Advagene Biopharma Co., Ltd. | 93.33 Million TWD | 28.352% |
| NaviFUS Corp. | 11.82 Million TWD | -465.427% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 190.72 Million TWD | 64.938% |
| Sinew Pharma Inc. | 186.25 Million TWD | 64.096% |
| Andros Pharmaceuticals Co.,Ltd | 74.02 Million TWD | 9.659% |
| Greenyn Biotechnology Co., Ltd | 220.39 Million TWD | 69.658% |
| Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | -61.214% |
| AP Biosciences Inc | 32.25 Million TWD | -107.339% |
| Medigen Biotechnology Corp. | 1.85 Billion TWD | 96.386% |
| 3D Global Biotech Inc. | 5.27 Million TWD | -1167.975% |
| Pharmosa Biopharm Inc. | 317.32 Million TWD | 78.926% |
| Intech Biopharm Corporation | -163.99 Million TWD | 140.777% |
| Oneness Biotech Co., Ltd. | 1.12 Billion TWD | 94.078% |
| Eusol Biotech Co.,Ltd. | 41.48 Million TWD | -61.21% |
| TWi Biotechnology, Inc. | 169.55 Million TWD | 60.56% |
| Ever Supreme Bio Technology Co., Ltd | 147.02 Million TWD | 54.515% |
| TCI GENE Inc. | 174.61 Million TWD | 61.703% |
| MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -371416.667% |
| Senhwa Biosciences, Inc. | 300.93 Million TWD | 77.778% |
| Taiwan Bio Therapeutics Co., Ltd | 290.95 Million TWD | 77.016% |
| NatureWise Biotech & Medicals Corporation | 83.94 Million TWD | 20.337% |
| PharmaEngine, Inc. | 441.78 Million TWD | 84.863% |
| Savior Lifetec Corporation | 223.36 Million TWD | 70.062% |
| TaiGen Biopharmaceuticals Holdings Limited | 258.77 Million TWD | 74.158% |
| OBI Pharma, Inc. | 2.01 Billion TWD | 96.683% |
| Meribank Biotech Co., Ltd | 138.87 Million TWD | 51.845% |
| Acepodia, Inc. | 452.56 Million TWD | 85.224% |
| Caliway Biopharmaceuticals Co., Ltd. | 540.93 Million TWD | 87.638% |